Correction to: Modern Pathology advance online publication, 18 March 2016; doi:10.1038/modpathol.2016.45
In this paper, the name of the ninth author is incorrect; the correct name Keila E Torres.
Additional information
The online version of the original article can be found at 10.1038/modpathol.2016.45
Rights and permissions
About this article
Cite this article
Cleven, A., Al Sannaa, G., Briaire-de Bruijn, I. et al. Erratum: Loss of H3K27 tri-methylation is a diagnostic marker for malignant peripheral nerve sheath tumors and an indicator for an inferior survival. Mod Pathol 29, 1113 (2016). https://doi.org/10.1038/modpathol.2016.103
Published:
Issue Date:
DOI: https://doi.org/10.1038/modpathol.2016.103
This article is cited by
-
Efficacy of MEK inhibition in a recurrent malignant peripheral nerve sheath tumor
npj Precision Oncology (2021)
-
The rare primary bone sarcomas: imaging-pathological correlation
Skeletal Radiology (2021)
-
Circulating tumor DNA for malignant peripheral nerve sheath tumors in neurofibromatosis type 1
Journal of Neuro-Oncology (2021)
-
Current Update on the Molecular Biology of Cutaneous Sarcoma: Dermatofibrosarcoma Protuberans
Current Treatment Options in Oncology (2019)
-
Loss of H3K27 trimethylation is not suitable for distinguishing malignant peripheral nerve sheath tumor from melanoma: a study of 387 cases including mimicking lesions
Modern Pathology (2017)
